Xenosure Biologic Patch
Payments companies reported to CMS as associated with Xenosure Biologic Patch. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xenosure Biologic Patch, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xenosure Biologic Patch
These are the largest totals companies reported as associated with Xenosure Biologic Patch. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Lieb | Hainesport, NJ | Vascular Surgery | $23,534.52 |
| Thomas Bernik | New York, NY | Vascular Surgery | $18,151.31 |
| William Raible | Albany, NY | Surgery | $16,366.86 |
| Tejas Shah | Downers Grove, IL | Vascular Surgery | $3,375.00 |
| Sandip Maru | Holyoke, MA | Vascular Surgery | $2,191.41 |
| George Koullias | East Patchogue, NY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $2,000.00 |
| Aqeel Siddiqui | Brockton, MA | Vascular Surgery | $500.00 |
| Homayoun Hashemi | Fairfax, VA | Vascular Surgery | $449.77 |
| Jessica Secor | Albuquerque, NM | Vascular Surgery | $173.30 |
| Barbara Melendez | Denver, CO | Vascular Surgery | $153.97 |
Prescribed Xenosure Biologic Patch?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.